Selexipag in the management of pulmonary arterial hypertension: an update

Overview of attention for article published in Drug, Healthcare and Patient Safety, August 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 42 Mendeley

Summary X Patents Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Ameliorating the Poor Dissolution Rate of Selexipag in Aqueous Acidic Conditions Following Confinement into Mesoporous Silica

Article in Indian Journal of Pharmaceutical Education and Research (October 2023)

Prevalence, patient characteristics and treatment patterns among systemic lupus erythematosus–pulmonary arterial hypertension patients in real-world clinical practice: A retrospective analysis of Medical Data Vision Database in Japan

Article in Modern Rheumatology (September 2023)

Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension

Article in Pulmonary Circulation (October 2022)